Capricor Therapeutics | CAPR - Equity Capital And Reserves


Capricor Therapeutics reported $278.7M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 278.7M 27.09M Mar/2026
Cipla INR 344.32B 15.13B Mar/2026
Cytokinetics USD -826.57M 166.94M Mar/2026
Geron USD 229.11M 3.24M Mar/2026
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 151.23M 157.91M Mar/2026
J&J USD 81.19B 358M Mar/2026
Plus Therapeutics USD 11.96M 7.96M Mar/2026
Prothena USD 312.62M 32.14M Mar/2026
PTC Therapeutics USD -180.46M 24.85M Mar/2026
Sarepta Therapeutics USD 1.51B 364.48M Mar/2026